DEA Wants 20% Reduction in Opioids
The agency says that the reduction lines up with current demand for opioids.
Express Scripts Kicks Out EpiPen Competitors
Big changes for EpiPen and more in Express Scripts’ formulary.
Increased Poison Center Calls Due to Supplements
A new study shows that supplement exposure rates have been increasing-pharmacists have a responsibility to slow those rates.
Two Pharmacists Involved in Multimillion Dollar Scam
A compounding fraud scheme cost taxpayers millions-and could put two pharmacists in prison.
Cyclobenzaprine HCl and Amantadine HCl Recalls
Aspace Packaging recalls two drugs due to potential mislabeling.
Walgreens Finds New Manufacturer
The chain signs a deal with Fareva to take over its contract manufacturing business.
Is a $150 Million Fine Just the Start of Trouble for AbbVie?
The maker of Androgel will face a series of trials after its most recent court loss.
Biosimilar of Remicade Launched
Renflexis has wholesale cost 35% below Remicade.
Pharmacist Intervention Helps Elderly Patients
A new study shows that a pharmacist-physician team can lower inappropriate drug use.
Safeway Pharmacy Pays $3 Million After DOJ Investigation
The chain is accused of not reporting opioid thefts by its employees.
Allergic Kids Aren’t Getting Enough Epinephrine
A new study shows that only a third of children suffering allergic reactions receive epinephrine immediately.
Record Attendance at AACP Annual Meeting
Thousands of faculty and students gathered to hear about the latest in healthcare.
When Switching Meds Isn’t the Best Approach
Study finds that adding an antipsychotic to antidepressant therapy may be best for treating depression.
Drug Manufacturer Pays Settlement Over Opioid
Mallinckrodt to pay settlement for not reporting orders or keeping accurate records.
A Drug Causes Hundreds of Deaths and Millions of ADEs
An investigation into Actemra (tocilizumab) has uncovered hundreds of serious adverse drug events, but the drug's labeling has not been changed.
Clinical Challenge: What Would You Do?
Preventing drug-drug interactions with HIV ART
FDA Approves First Drug for Sickle Cell in 20 Years
Endari is only the second FDA-approved sickle cell disease drug.
New Drug Review: Sarilumab
The FDA approved Kevzara for RA patients.
The Impact of a Pharmacist as a Health Coach
A look at the ways coaching your patients can leave them healthier.
New Board Certifications Show Increasing Complexity of Pharmacy
BPS has been adding more board certifications-but they're not done yet.
Pharmacist Personal Beliefs in the News Again
A New Mexico pharmacist's actions brought an ACLU lawsuit.
How to Beat the Opioid Crisis
Getting the Morning-After Pill Remains a Challenge for Many Teens
New study indicates emergency contraception is not available to all who might need it.
FDA Fast-Tracks Orphan Drugs
The agency is trying to deliver on its goal of a 90-day response time.
493% Increase in Opioid Use Disorder Diagnoses
A new BCBS study finds that 21% of insured members filled at least one opioid script in 2015.
Lab Testing Coming to Walgreens
A collaboration between the pharmacy and LabCorp will provide specimen collection services.
Dietary Supplements or Unapproved Drugs?
Why some red yeast rice supplements could be considered prescription drugs.
Omnicell and CompleteRx Join Forces
Two groups join up to help the Massachusetts State Office of Pharmacy Services.
New Partnership Aids Specialty Pharmacists
Specialty Drugs: Unintended Consequences May Slow the Market
Report looks at possible impediments to growth in the specialty market, including patient access.
